Skip to main content
. Author manuscript; available in PMC: 2022 Aug 3.
Published in final edited form as: Prog Lipid Res. 2022 May 1;86:101165. doi: 10.1016/j.plipres.2022.101165

Fig. 5.

Fig. 5.

Eicosanoids, docosanoids, and elovanoids. PLAs that release ARA, EPA, DHA, or VLC-PUFAs are depicted at the top. Synthesis of mediators and receptors involved are illustrated. The outcome is modulation of inflammatory responses and homeostasis. AD, Alzheimer’s disease; AMD, age-related macular degeneration; VLC-PUFA, very long-chain PUFA. Reproduced, with permission from the Journal of Lipid Research [178].